Confo Therapeutics

Confo Therapeutics' unparalleled technology stabilizes the functional conformations of GPCRs (G protein-coupled receptors), thereby uncovering a series of previously inaccessible GPCRs as drug targets. The technology platform, combined with the pharmacological and biological insights it provides, enables Confo to build a multi-indication pipeline of drug candidates, which has the potential to transform treatment outcomes for patients with serious diseases that lack effective therapies.